5 Reasons Every Oncology MSL Should Rely on KOL Pulse

The short version: Oncology MSLs need to know what experts are saying right now — and feed that intelligence straight into the AI tools they (and their physicians) use every day. KOL Pulse delivers real-time ASCO and congress updates, AI-native clinical trial profiles, smaller-meeting summaries, and live KOL network mapping — all structured so ChatGPT, Claude, Perplexity, and NotebookLM can read and cite it. Veeva and Larvol keep their intelligence inside a licensed platform, which caps what your AI can do with it.

Veeva Link markets “real-time intelligence on key people — scientific, digital, and community leaders,” and Larvol offers “real-time reactions on data releases from over 5,000 verified oncologists on X.” Both are genuinely good at what they were built for: curated, comprehensive KOL and competitive-intelligence databases. But the MSL’s world has changed. Physicians increasingly answer their own clinical questions inside AI tools, and the deciding factor is no longer who has the data — it’s whose data your AI workflow can reach and act on. That’s the gap KOL Pulse fills.

1. Real-time ASCO (and every congress) updates — built to drop into your AI workflow

When ASCO, ESMO, ASH, or SABCS is live, an insight’s half-life is hours. KOL Pulse captures the conference conversation as it happens — top voices, hot abstracts, trial buzz, and the debates forming on the floor — on a page your team and your AI tools can use immediately.

vs. Veeva / Larvol: Larvol’s conference coverage and Veeva’s real-time alerts are strong, but the output lands inside their platform or a curated recap. KOL Pulse’s congress intelligence is published as an AI-native, machine-readable page — so you can paste it into Claude or NotebookLM for grounded prep, and answer engines can cite it.

2. AI-native clinical trial profiles

Every major readout gets a KOL Pulse trial profile: the data, the KOL sentiment, the slide text, the regulatory status, and the top voices — one page, structured with answer capsules and schema so it works as a clean “context object” for any AI tool.

vs. Veeva / Larvol: Veeva’s strength is the Key People profile (3M+ experts across publications, trials, congresses, payments, and social), and Larvol’s is oncology drug/CI intelligence. Both are people- or competitor-centric and live behind a login. KOL Pulse’s trial-centric, sentiment-rich profiles are designed from the ground up to be read — and cited — by AI.

3. Smaller-meeting summaries — the conversations the big platforms don’t prioritize

The major congresses are covered by everyone. The edge is in the long tail: regional symposia, satellite sessions, tumor-board debates, X journal clubs, and KOL podcasts. KOL Pulse summarizes these smaller, high-signal moments where practice-changing opinions often form first. Check out the important coverage of #EHA26 or #ESMOBreast26

vs. Veeva / Larvol: their curated databases and conference planners index the formal record and the big meetings exceptionally well. The informal, fast-moving layer where digital opinion leaders actually shape practice is harder to systematize — and it’s exactly where KOL Pulse focuses.

4. Network mapping — when a KOL talks, who actually listens?

Influence isn’t a title or a profile score. KOL Pulse maps the amplification network: when a given oncologist posts, who reacts, quotes, and spreads it — which peers, institutions, and patient advocates. That shows an MSL who the real nodes are and how an idea will travel through the community.

vs. Veeva / Larvol: Veeva profiles a KOL’s influence on community practice as an attribute of the person; KOL Pulse shows the living network around the message — not just how influential someone is rated, but who is listening when they speak, right now. View the virtual attendee network analysis of EHA26.

5. Open and AI-native — why a closed system limits your AI outcomes

This reason ties the other four together. Veeva delivers its intelligence “via web application, API, and data file” and integrates with Veeva CRM; its Medical Insights AI clusters your MSL notes into themes — inside the Veeva ecosystem, with “expert human review.” Larvol distills 25,000+ sources into curated reports for its platform. Both are, by design, licensed, closed environments.

KOL Pulse takes the opposite approach. It’s AI-native and open: pages are machine-readable, answer-engine-optimized, and built to be consumed by the tools MSLs and oncologists actually use — ChatGPT, Claude, Perplexity, OpenEvidence, NotebookLM. When AI is doing the reasoning, the intelligence your model can reach and cite beats the intelligence locked in someone else’s dashboard. A closed system caps the AI outcome; an open one compounds it.

KOL Pulse vs. Veeva Link vs. Larvol — for an oncology MSL

Sources: Veeva Link overview, Key People, Medical Insights; Larvol, CLIN. Comparison reflects design philosophy (open/AI-native vs. closed/curated).

Frequently asked questions

Compiled and reviewed by the KOL Pulse research team, led by Brian Shields, Founder, KOL Pulse. Last updated June 2026.